{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:43:40Z","timestamp":1793853820911,"version":"4.6.1"},"reference-count":42,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1610,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1600-0714.2011.01029.x","type":"journal-article","created":{"date-parts":[[2011,4,5]],"date-time":"2011-04-05T06:42:26Z","timestamp":1301985746000},"page":"521-524","source":"Crossref","is-referenced-by-count":32,"title":["Biologics, an alternative therapeutic approach for oral lichen planus"],"prefix":"10.1111","volume":"40","author":[{"given":"Jing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge-Fei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Mei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,4,5]]},"reference":[{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00128071-200001050-00004","article-title":"Management of oral lichen planus","volume":"1","author":"Scully","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tripleo.2004.06.077","article-title":"Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis","volume":"100","author":"Lodi","year":"2005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0738-081X(00)00142-5","article-title":"Oral lichen planus","volume":"18","author":"Sugerman","year":"2000","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/154411130201300405","article-title":"The pathogenesis of oral lichen planus","volume":"13","author":"Sugerman","year":"2002","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clindermatol.2009.03.004","article-title":"Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies","volume":"28","author":"Farhi","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/S0190-9622(03)01141-1","article-title":"Efalizumab: an overview","volume":"49","author":"Leonardi","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2133.2000.03355.x","article-title":"Auto-cytotoxic T cell clones in lichen planus","volume":"142","author":"Sugerman","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2334\/josnusd.50.377","article-title":"Steriods in the treatment of lichen planus: a review","volume":"50","author":"Thongprasom","year":"2008","journal-title":"J Oral Sci"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1054\/bjom.2000.0335","article-title":"Oral lichen planus: a review","volume":"38","author":"Mollaoglu","year":"2000","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00128071-200203030-00001","article-title":"Topical corticosteroid-induced adrenocortical insufficiency: clinical implications","volume":"3","author":"Levin","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/187221309787158425","article-title":"Contact allergy to topical corticosteroids: update and review on cross-sensitization","volume":"3","author":"Foti","year":"2009","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1210\/jc.2008-0040","article-title":"Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder","volume":"93","author":"Charmandari","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB13|cit13","first-page":"519","article-title":"Oral lichen planus: a review","volume":"58","author":"Carrozzo","year":"2009","journal-title":"Minerva Stomatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.annder.2007.06.010","article-title":"Photopheresis: an alternative therapeutic approach in corticoresistant erosive oral lichen planus","volume":"135","author":"Marchesseau-Merlin","year":"2008","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/0019-5154.62754","article-title":"Biological therapy of psoriasis","volume":"55","author":"Sivamani","year":"2010","journal-title":"Indian J Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1601-0825.2008.01440.x","article-title":"Biologic treatments for systemic rheumatic diseases","volume":"14","author":"Shirota","year":"2008","journal-title":"Oral Dis"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/j.1365-2133.2010.09704.x","article-title":"Guidance on the use of biological agents in the treatment of oral mucosal disease","volume":"162","author":"O\u2019Neill","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1600-0714.2008.00693.x","article-title":"Off-label use of biologicals in the management of inflammatory oral mucosal disease","volume":"37","author":"O\u2019Neill","year":"2008","journal-title":"J Oral Pathol Med"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.clindermatol.2007.10.028","article-title":"Alefacept in the treatment of psoriasis","volume":"26","author":"Sugiyama","year":"2008","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM200107263450403","article-title":"Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes","volume":"345","author":"Ellis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archderm.142.2.151","article-title":"Treatment of generalized lichen planus with alefacept","volume":"142","author":"Fivenson","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB22|cit22","first-page":"379","article-title":"Alefacept for erosive lichen planus: a case series","volume":"7","author":"Chang","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.autrev.2006.12.002","article-title":"Biologic therapies in psoriasis: a new therapeutic approach","volume":"6","author":"Gisondi","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-alpha and inducible nitricoxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)","volume":"102","author":"Lowes","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1001\/archderm.142.6.680","article-title":"Oral erosive lichen planus treated with efalizumab","volume":"142","author":"Cheng","year":"2006","journal-title":"Arch Dermatol"},{"issue":"Suppl","key":"10.1111\/j.1600-0714.2011.01029.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.jaad.2006.10.957","article-title":"Lichen planus responding to efalizumab","volume":"56","author":"B\u00f6hm","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB27|cit27","first-page":"310","article-title":"A single-center, open-label, prospective pilot study of subcutaneous efalizumab for oral erosive lichen planus","volume":"6","author":"Heffernan","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archdermatol.2009.175","article-title":"Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists","volume":"145","author":"Korman","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaad.2004.12.032","article-title":"Biologic treatments for psoriasis","volume":"52","author":"Kipnis","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-0714.1996.tb01375.x","article-title":"Is there a role for tumour necrosis factor-alpha (TNF-\u03b1) in oral lichen planus?","volume":"25","author":"Sugermann","year":"1996","journal-title":"J Oral Pathol Med"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0003-9969(99)00013-8","article-title":"Distribution of interleukin-2,-4,-10, tumour necrosis factor-\u03b1 and transforming growth factor-\u03b2mRNAs in oral lichen planus","volume":"44","author":"Simark-Mattsson","year":"1999","journal-title":"Arch Oral Biol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/00128071-200708020-00010","article-title":"Etanercept for the management of oral lichen planus","volume":"8","author":"Yarom","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB33|cit33","first-page":"325","article-title":"Adalimumab in the management of cutaneous and oral lichen planus","volume":"84","author":"Chao","year":"2009","journal-title":"Cutis"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaad.2008.09.032","article-title":"Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists","volume":"61","author":"Asarch","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.transproceed.2010.01.039","article-title":"Induction with basiliximab in renal transplantation","volume":"42","author":"Ferrer","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/archderm.138.8.1100","article-title":"Basiliximab is effective for erosive lichen planus","volume":"138","author":"Rebora","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"e2461","DOI":"10.1371\/journal.pone.0002461","article-title":"Exosomes derived from M. bovis BCG infected macrophages activate antigen-specific CD4+ and CD8+ T cells in vitro and in vivo","volume":"3","author":"Giri","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB38|cit38","first-page":"5","article-title":"Regulation of BCG-polysaccharide nucleic acid on Thl\/Th2 cytokines from peripheral blood mononuclear cells in oral lichen planus","volume":"7","author":"Zhou","year":"2004","journal-title":"Chin J Dent Res"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1600-0714.2009.00796.x","article-title":"The efficacy of topical intralesional BCG-PSN injection in the treatment of erosive oral lichen planus: a randomized controlled trial","volume":"38","author":"Xiong","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1529-8019.2007.00141.x","article-title":"Off-label uses of rituximab in dermatology","volume":"20","author":"Carr","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.det.2010.03.002","article-title":"Innovative uses of rituximab in dermatology","volume":"28","author":"Carr","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1111\/j.1600-0714.2011.01029.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/archderm.144.11.1427","article-title":"Mucocutaneous lichen planus with esophageal involvement: successful treatment with an anti-CD20 monoclonal antibody","volume":"144","author":"Parmentier","year":"2008","journal-title":"Arch Dermatol"}],"container-title":["Journal of Oral Pathology & Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0714.2011.01029.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0714.2011.01029.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T11:21:43Z","timestamp":1625656903000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0714.2011.01029.x"}},"subtitle":["Biologics for OLP"],"short-title":[],"issued":{"date-parts":[[2011,4,5]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0714.2011.01029.x","relation":{},"ISSN":["0904-2512"],"issn-type":[{"value":"0904-2512","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4,5]]}}}